Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption
- PMID: 15569619
- DOI: 10.2741/1573
Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption
Abstract
Myo-inositol hexakisphosphate (InsP6, phytate) is a molecule to which diverse beneficial properties have been attributed. Some of these properties are related to its dermatological use as discolouring agent, on preventing calcinosis cutis or due to its important role on premature aging. Other studies also seem to demonstrate a capacity of InsP6 to inhibit skin cancer. In this paper, the effect of the vehicle of topical administration of phytate is studied, using four groups of male Wistar rats (n = 6) fed with an InsP6 defficient diet and treated with a hydrophyl gel or an O/W moisturizing cream with two different concentrations of InsP6. Due to the correlation between InsP6 absorption and its urinary excretion, these last values were used to evaluate this process. It was found that phytate was absorbed through the skin using both a gel or a cream, demonstrating that its absorption is independent on the matrix used for topical treatment. However, urinary InsP6 values were slightly higher when using the gel, but in all cases values were much higher than those found with oral InsP6 treatment, due to the formation of insoluble species in the gastrointestinal tract when InsP6 is administered orally.
Similar articles
-
Study of the absorption of myo-inositol hexakisphosphate (InsP6) through the skin.Biol Pharm Bull. 2005 Apr;28(4):764-7. doi: 10.1248/bpb.28.764. Biol Pharm Bull. 2005. PMID: 15802828
-
Absorption of myo-inositol hexakisphosphate (InsP6) through the skin in humans.Pharmazie. 2006 Jul;61(7):652. Pharmazie. 2006. PMID: 16889078
-
Evaluation of inositol phosphates in urine after topical administration of myo-inositol hexaphosphate to female Wistar rats.Life Sci. 2018 Jan 1;192:33-37. doi: 10.1016/j.lfs.2017.11.023. Epub 2017 Nov 16. Life Sci. 2018. PMID: 29155299
-
Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.Molecules. 2019 Dec 4;24(24):4434. doi: 10.3390/molecules24244434. Molecules. 2019. PMID: 31817119 Free PMC article. Review.
-
Plant phosphates, phytate and pathological calcifications in chronic kidney disease.Nefrologia. 2017 Jan-Feb;37(1):20-28. doi: 10.1016/j.nefro.2016.07.001. Epub 2016 Sep 30. Nefrologia. 2017. PMID: 27697413 Review. English, Spanish.
Cited by
-
Effect of phytate on hypercalciuria secondary to bone resorption in patients with urinary stones: pilot study.Urolithiasis. 2022 Dec;50(6):685-690. doi: 10.1007/s00240-022-01357-8. Epub 2022 Sep 10. Urolithiasis. 2022. PMID: 36087116 Free PMC article. Clinical Trial.
-
Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial.Nutr Diabetes. 2023 Feb 28;13(1):2. doi: 10.1038/s41387-023-00231-9. Nutr Diabetes. 2023. PMID: 36854678 Free PMC article. Clinical Trial.
-
Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy.J Pers Med. 2021 Jul 30;11(8):756. doi: 10.3390/jpm11080756. J Pers Med. 2021. PMID: 34442400 Free PMC article.
-
Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases.Nutrients. 2021 Aug 20;13(8):2859. doi: 10.3390/nu13082859. Nutrients. 2021. PMID: 34445019 Free PMC article.
-
Estimated Phytate Intake Is Associated with Bone Mineral Density in Mediterranean Postmenopausal Women.Nutrients. 2023 Apr 6;15(7):1791. doi: 10.3390/nu15071791. Nutrients. 2023. PMID: 37049631 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources